Literature DB >> 3396811

Comparison of gastric acid secretion rates and serum pepsinogen I and II concentrations in Occidental and Oriental duodenal ulcer patients.

M Feldman1, C T Richardson, S K Lam, I M Samloff.   

Abstract

The purpose of these controlled studies was to determine the prevalence of acid-pepsinogen hypersecretion in 173 patients with duodenal ulcer disease [88 Americans (75 men, 13 women) and 85 Chinese (66 men, 19 women)]. One-half to two-thirds of duodenal ulcer patients of either sex had acid hypersecretion or hyperpepsinogenemia, or both. When Chinese and American duodenal ulcer patients were compared, the two ethnic groups had similar serum pepsinogen I and II concentrations and similar maximal acid outputs per kilogram body weight. In contrast, Chinese duodenal ulcer patients had significantly lower basal acid outputs per kilogram body weight than American duodenal ulcer patients. We conclude that acid-pepsinogen hypersecretion is present in the majority of American and oriental duodenal ulcer patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396811     DOI: 10.1016/s0016-5085(88)80008-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  20 in total

1.  Comparative study of therapeutic effects of PPI and H2RA on ulcers during continuous aspirin therapy.

Authors:  Hiroaki Nema; Mototsugu Kato
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

2.  Fasting gastric pH and its relationship to true hypochlorhydria in humans.

Authors:  M Feldman; C Barnett
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

3.  Effect of short-term omeprazole administration on serum pepsinogens in relation to fasting serum gastrin and gastric acid secretion.

Authors:  I Biemond; L F Crobach; J B Jansen; C B Lamers
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  The role of serum pepsinogen in the detection of gastric cancer.

Authors:  Nayoung Kim; Hyun Chae Jung
Journal:  Gut Liver       Date:  2010-09-24       Impact factor: 4.519

5.  Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication.

Authors:  Katsunori Iijima; Tomoyuki Koike; Yasuhiko Abe; Nobuyuki Ara; Kaname Uno; Akira Imatani; Shuichi Ohara; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2009-05-14       Impact factor: 7.527

6.  Bisphosphonate increases risk of gastroduodenal ulcer in rheumatoid arthritis patients on long-term nonsteroidal antiinflammatory drug therapy.

Authors:  Kazumasa Miyake; Masanori Kusunoki; Yoko Shinji; Tomotaka Shindo; Tetsuro Kawagoe; Seiji Futagami; Katya Gudis; Taku Tsukui; Atsushi Nakajima; Choitsu Sakamoto
Journal:  J Gastroenterol       Date:  2009-02-13       Impact factor: 7.527

7.  Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE--famotidine or rebamipide in comparison by endoscopy).

Authors:  Jun-ichi Yamao; Eiryo Kikuchi; Masami Matsumoto; Masaki Nakayama; Tatsuichi Ann; Hideyuki Kojima; Akira Mitoro; Motoyuki Yoshida; Masaaki Yoshikawa; Hiroshi Yajima; Yoshizumi Miyauchi; Hiroshi Ono; Koichi Akiyama; Goro Sakurai; Yoshikazu Kinoshita; Ken Haruma; Yoshinori Takakura; Hiroshi Fukui
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

8.  Serum pepsinogen I concentrations in peptic ulcer patients in relation to ulcer location and stage.

Authors:  Y Tanaka; K Mine; Y Nakai; N Mishima; T Nakagawa
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

9.  Circadian pattern of intragastric acidity in duodenal ulcer patients: a study of variations in relation to ulcer activity.

Authors:  S Wagner; U Gladziwa; M Gebel; A Schüler; J Freise; F W Schmidt
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

10.  Effect of Helicobacter pylori infection on 24 hour intragastric acidity in patients with gastritis and duodenal ulcer.

Authors:  S Wagner; U Gladziwa; K Haruma; M Varrentrapp; M Gebel
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.